169 related articles for article (PubMed ID: 29523824)
1. Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii.
Hornsey M; Wareham DW
Sci Rep; 2018 Mar; 8(1):4234. PubMed ID: 29523824
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.
Hornsey M; Loman N; Wareham DW; Ellington MJ; Pallen MJ; Turton JF; Underwood A; Gaulton T; Thomas CP; Doumith M; Livermore DM; Woodford N
J Antimicrob Chemother; 2011 Jul; 66(7):1499-503. PubMed ID: 21565804
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
Jo J; Ko KS
Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
[TBL] [Abstract][Full Text] [Related]
5. Novel tigecycline resistance mechanisms in
Hua X; He J; Wang J; Zhang L; Zhang L; Xu Q; Shi K; Leptihn S; Shi Y; Fu X; Zhu P; Higgins PG; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1404-1417. PubMed ID: 34170209
[No Abstract] [Full Text] [Related]
6. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.
Hornsey M; Ellington MJ; Doumith M; Thomas CP; Gordon NC; Wareham DW; Quinn J; Lolans K; Livermore DM; Woodford N
J Antimicrob Chemother; 2010 Aug; 65(8):1589-93. PubMed ID: 20554571
[TBL] [Abstract][Full Text] [Related]
7. The distribution of mutations and hotspots in transcription regulators of resistance-nodulation-cell division efflux pumps in tigecycline non-susceptible Acinetobacter baumannii in China.
Xu Q; Hua X; He J; Zhang D; Chen Q; Zhang L; Loh B; Leptihn S; Wen Y; Higgins PG; Yu Y; Zhou Z
Int J Med Microbiol; 2020 Dec; 310(8):151464. PubMed ID: 33130415
[TBL] [Abstract][Full Text] [Related]
8. [Molecular epidemiology and resistance mechanisms of tigecycline-non-susceptible Acinetobacter baumannii].
He X; Li H; Wang Q; Zhao C; Li S; Wang X; Zhang Y; Wang R; Yin Y; Jin L; Zhang F; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1218-1225. PubMed ID: 30152207
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.
Haeili M; Abdollahi A; Ahmadi A; Khoshbayan A
Chemotherapy; 2021; 66(3):99-106. PubMed ID: 33823517
[TBL] [Abstract][Full Text] [Related]
10. Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination.
Sato Y; Ubagai T; Tansho-Nagakawa S; Yoshino Y; Ono Y
Sci Rep; 2021 Jun; 11(1):11700. PubMed ID: 34083569
[TBL] [Abstract][Full Text] [Related]
11. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii.
Yoon EJ; Chabane YN; Goussard S; Snesrud E; Courvalin P; Dé E; Grillot-Courvalin C
mBio; 2015 Mar; 6(2):. PubMed ID: 25805730
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of blaNDM-1, blaOXA-51, blaOXA-23, and armA in conjunction with novel mutations detected in RND efflux pump regulators in tigecycline resistant clinical isolates of Acinetobacter baumannii.
Sawant AR; Pagal S; Amar AK; Panda L; Devi C S; Shashikala P; Kanungo R; Prashanth K
Pathog Dis; 2022 Jul; 80(1):. PubMed ID: 35704614
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Efflux Pump System and Other Drug Resistance Related Gene Mutations in Tigecycline-Resistant
Zheng W; Huang Y; Wu W; Zhu J; Zhang T
Comput Math Methods Med; 2023; 2023():8611542. PubMed ID: 36846201
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
[TBL] [Abstract][Full Text] [Related]
15. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z
Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584
[TBL] [Abstract][Full Text] [Related]
16. Isolation and Characterization of a Novel
Wintachai P; Surachat K; Singkhamanan K
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
[TBL] [Abstract][Full Text] [Related]
17. Alteration of
Yang Y; Liu X; Zhou D; He J; Chen Q; Xu Q; Wu S; Zhang W; Yao Y; Fu Y; Hua X; Yu Y; Wang X
Microbiol Spectr; 2023 Jun; 11(3):e0459422. PubMed ID: 37184390
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
Peleg AY; Adams J; Paterson DL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in
Karakonstantis S
J Chemother; 2021 Feb; 33(1):1-11. PubMed ID: 32677578
[TBL] [Abstract][Full Text] [Related]
20. [Resistance of
Qu JY; Ü XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):248-252. PubMed ID: 28612536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
